Your browser doesn't support javascript.
loading
Ocular Manifestations of Antiphospholipid Syndrome in Jordan.
Al-Zubi, Khalid; Sarayrah, Fawaz.
Afiliación
  • Al-Zubi K; Department of Special Surgery, Faculty of Medicine, Mutah University, Al-Karak, Jordan.
  • Sarayrah F; Department of Special Surgery, Faculty of Medicine, Mutah University, Al-Karak, Jordan.
Middle East Afr J Ophthalmol ; 29(4): 205-208, 2022.
Article en En | MEDLINE | ID: mdl-38162563
ABSTRACT

PURPOSE:

The purpose of the study was to evaluate the prevalence of various ocular manifestations in diagnosed cases of antiphospholipid syndrome (APS) in Jordan. It will also find the association of these manifestations with primary and secondary APS.

METHODS:

It was a retrospective cross-sectional study to analyze the ocular manifestations of APS in Jordan. Data of 90 cases were obtained from public hospitals from January 2018 to January 2021. There should have been at least two positive tests with a minimum of 12-week gap between them. The electronic data regarding Schirmer tests, examination of visual acuity (Snellen acuity), neuro-ophthalmic manifestations, dilated fundus examination for posterior eye segment manifestations, and slit-lamp examination for anterior eye segment were also recorded and analyzed. Using SPSS version 25, the frequency and percentages of the categorical data were computed. Pearson's Chi-square test was conducted to find the associations.

RESULTS:

Among 90 APS cases, 52 (58%) patients had primary APS and 38 (42%) had secondary APS. At the same time, systemic lupus erythematosus was diagnosed in 31 (34%) patients. Keratoconjunctivitis sicca (dry eyes), decreased vision, and retinal vasculitis were the most common manifestations observed.

CONCLUSION:

The high prevalence of ocular manifestations warrants ophthalmologists to look for APS, as ocular manifestations could be the initial symptoms and/or signs of APS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Antifosfolípido / Lupus Eritematoso Sistémico Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Middle East Afr J Ophthalmol Año: 2022 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Antifosfolípido / Lupus Eritematoso Sistémico Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Middle East Afr J Ophthalmol Año: 2022 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: India